A new rapid home test for Faecal Calprotectin in Ulcerative Colitis
Margarita Elkjaer, Johan Burisch, Vibeke Voxen Hansen, Birgit Deibjerg Kristensen, Jens-Kristian
Slott Jensen, Pia Munkholm
Aliment Pharmacol Ther 2009 31(2):323-30
Development of a Web-based concept for patients with Ulcerative Colitis and 5-Aminosalicylic acid treatment.
Margarita Elkjaer, Johan Burisch, Søren Avnstrøm, Elsebeth Lynge, Pia Munkholm
Eur J Gastroenterol Hepatol 2010 22(6):695-704
E-health empowers patients with Ulcerative Colitis through web-guided concept Constant-care. Running head: The web-guided concept Constant-care in UC
Margarita Elkjaer, Mary Shuhaibar, Johan Burisch, Yvonne Bailey, Hanne Scherfig, Birgit Laugesen, Søren Avnstrøm, Ebbe Langholz, Colm O´Morain, Elsebeth Lynge, Pia Munkholm
Gut. 2010 Dec;59(12):1652-61.
Construction and validation of a web-based epidemiological database in Europe
Burisch J, Cukovic-Cavka S, Kaimakliotis I, Shonová O, Andersen V, Dahlerup JF, Elkjaer M, Langholz E, Pedersen N, Salupere R, Kolho KL, Manninen P, Lakatos PL, Shuhaibar M, Odes S, Martinato M, Mihu I, Magro F, Belousova E, Fernandez A, Almer S, Halfvarson J, Hart A, Munkholm P. for the EpiCom-group
J Crohns Colitis. 2011 Aug;5(4):342-9.
E-Health: Individualization of Infliximab Treatment and Disease Course via Self-managed Web-based Solution in Crohn's Disease.
Natalia Pedersen, Margarita Elkjaer, Dana Duricova, Johan Burisch, Christian Dobrzanski, Nynne Nyboe Andersen, Tine Jess, Flemming Bendtsen, Ebbe Langholz, Salvatore Leotta, Torben Knudsen, Niels Thorsgaard, Pia Munkholm
Aliment Pharmacol Ther. 2012 Nov 12;36(9):840–9.
The burden of Inflammatory Bowel Disease in Europe
Johan Burisch, Tine Jess, Matteo Martinato, Peter L Lakatos on behalf of ECCO-EpiCom
J Crohns Colitis. 2013 May 1;7(4):322-37.
Inflammatory bowel disease epidemiology
Burisch J, Munkholm P.
Curr Opin Gastroenterol 2013 May 20;29(4):357–62
East-West gradient in the incidence of inflammatory bowel disease in Europe – the first ECCO-EpiCom inception cohort
Burisch J, Pedersen N, Cukovic-Cavka S, Brinar M, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Andersen V, Krabbe S, Dahlerup JF, Salupere R, Nielsen KR, Olsen J, Manninen P, Collin P, Tsianos EV, Katsanos KH, Ladefoged K, Lakatos L, Björnsson E, Ragnarsson G, Bailey Y, Odes S, Schwartz D, Martinato M, Lupinacci G, Milla M, De Padova A, D'Incà R, Beltrami M, Kupcinskas L, Kiudelis G, Turcan S, Tighineanu O, Mihu I, Magro F, Barros LF, Goldis A, Lazar D, Belousova E, Nikulina I, Hernandez V, Martinez-Ares D, Almer S, Zhulina Y, Halfvarson J, Arebi N, Sebastian S, Lakatos PL, Langholz E, Munkholm P, for the EpiCom-group.
Gut 2014;63(4):588–97.
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe – The ECCO-EpiCom cohort
Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, O’Morain C, Schwartz D, Odes S, Martinato M, Lombardini S, Jonaitis L, Kupcinskas L, Turcan S, Barros LF, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Tsai HH, Sebastian S, Lakatos PL, Langholz E and Munkholm P for the EpiCom-group.
Inflamm Bowel Dis 2014;20(1):36–46.
Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe – An ECCO-EpiCom study.
Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O’Morain C, Schwartz D, Odes S, Giannotta M, Girardin G, Kiudelis G, Kupcinskas L, Turcan S, Barros L, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Martinez-Ares D, Hernandez V, Almer S, Zhulina Y, Halfvarson J, Arebi N, Tsai HH, Sebastian S, Lakatos P, Langholz E and Munkholm P for the EpiCom-group
J Crohns Colitis. 2014 Jul 1;8(7):607-16
Crohn’s disease and ulcerative colitis – occurrence, course and prognosis during the 1st year of disease in a European population-based inception cohort
Burisch J.
Dan Med J 2014;61(1): B4778
Health care and patients' education in a European inflammatory bowel disease inception cohort – An ECCO-EpiCom study
Burisch J, Vegh Z, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Ragnarsson G, Björnsson E, Bailey Y, O’Morain C Schwartz D, Odes S, Politi P, Santini A, Kiudelis G, Kupcinskas L, Turcan S, Barros LF, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Sanroman L , Almer S, Zhulina Y, Halfvarson J, Arebi N, Houston Y, Sebastian S, Langholz E, Lakatos PL and Munkholm P for the EpiCom-group.
J Crohns Colitis 2014 Aug 1;8(8):811-8.
Health related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease – An ECCO-EpiCom study
Burisch J, Weimers P, Pedersen N, Cukovic-Cavka S, Vucelic B, Kaimakliotis I, Duricova D, Bortlik M, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Ragnarsson G, Björnsson E, Bailey Y, O’Morain C Schwartz D, Odes S, Valpiani D, Boni MC, Jonaitis L, Kupcinskas L, Turcan S, Barros LF, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Sanroman L , Almer S, Zhulina Y, Halfvarson J, Arebi N, Diggory T, Sebastian S, Lakatos PL, Langholz E and Munkholm P for the EpiCom-group.
J Crohns Colitis 2014 Sep 1;8(9):1030-42.
Associations between functional polymorphisms in the NFkB signalling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julie Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Ø Thomsen, Morten Frydenberg, Jacob Sode, Bjørn Andersen Nexø, Ulla Vogel and Vibeke Andersen
Pharmacogenomics J. 2014 Dec;14(6):526-34.
Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet
Natalia Pedersen, Zsuzsanna Vegh, Johan Burisch, Lisbeth Jensen, Dorit Vedel Andersen, Maria Felding, Nynne Nyboe Andersen, Pia Munkholm
World J Gastroenterol 2014 20(21):6680-6684
eHealth: Individualisation of MMX mesalazine treatment and optimization of disease course via a self-managed web-based solution in active ulcerative colitis
Natalia Pedersen, Peter Thielsen, Lars Martinsen, Mette Bennedsen, Anne Haaber, Ebbe Langholz, Zsuzsanna Végh, Dana Duricova, Tine Jess, Sally Bell, Johan Burisch, Pia Munkholm
Inflamm Bowel Dis. 2014 Dec;20(12):2276-85.
Age-related differences in presentation and course of inflammatory bowel disease: An update from the population-based literature
Dana Duricova*, Johan Burisch*, Tine Jess, Corinne Gower-Rousseau, Peter L. Lakatos on Behalf of ECCO-EpiCom
* contributed equally
J Crohns Colitis. 2014 Nov 1;8(11):1351-61
Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julie Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Ø Thomsen, Morten Frydenberg, Bjørn Andersen Nexø, Jacob Sode, Ulla Vogel and Vibeke Andersen
PLoS One. 2014 Jun 27;9(6):e98815
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort
Z Vegh, J Burisch, N Pedersen, I Kaimakliotis, D Duricova, I Vind, K K Vinding, J Olsen, KR Nielsen, KH Katsanos, EV Tsianos, L Lakatos, D Schwartz, S Odes, R D’Incà, S Lombardini, L Jonaitis, L Kupcinskas, S Turcan, O Tighineanu, I Mihu, L F Barros, F Magro, D Lazar, A Goldis, A Fernandez, V Hernandez, S Bell, O Niewiadomski, E Langholz, P Munkholm and P L Lakatos for the EpiCom-group
J Crohns Colitis. 2014 Nov 1;8(11):1506-15.
Ehealth: Low FODMAP and polyols vs Lactobacilus rhamnosus GG in irritable bowel syndrome
Natalia Pedersen, Nynne Nyboe Andersen, Zsuzsanna Végh, Lisbeth Jensen, Dorit Vedel Andersen, Maria Felding, Mette Hestetun, Johan Burisch, Pia Munkholm.
World J Gastroenterol. 2014 Nov 21;20(43):16215-26.
Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases.
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julie Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Østergaard Thomsen, Bjørn Andersen Nexø, Ulla Vogel and Vibeke Andersen
Dan Med J 2015;62(3): A4994
Costs and resource utilization during the initial year after diagnosis in a European inflammatory bowel disease inception cohort – An ECCO-EpiCom study
Burisch J, Vardi H, Pedersen N, Turk N, Cukovic-Cavka S, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup JF, Kjeldsen J, Salupere R, Olsen J, Nielsen KR, Manninen P, Collin P, Katsanos KH, Tsianos EV, Ladefoged K, Lakatos L, Bailey Y, O’Morain C, Schwartz D, Lupinacci G, De Padova A, Jonaitis L, Kupcinskas L, Turcan S, Barros LF, Magro F, Lazar D, Goldis A, Nikulina I, Belousova E, Fernandez A, Hernandez V, Almer S, Halfvarson J, Tsai HH, Sebastian S, Friger M, Greenberg D, Lakatos PL, Langholz E, Odes S and Munkholm P for the EpiCom-group
Inflamm Bowel Dis. 2015 Jan;21(1):121-31
[Editorial] Environment and invironment in inflammatory bowel disease: partners in crime
Lakatos PL, Burisch J
Gut 2015;64(7):1009-10
The epidemiology of inflammatory bowel disease
Burisch J, Munkholm P
Scand J Gastroenterol. 2015 Aug;50(8):942-51
Rejuvenating UEG: The Young Talent Group and the Young GI Network
Burisch J.
United European Gastroenterol J. 2015 Feb;3(1):99.
Treatment steps, surgery and hospitalization rates during the first year of follow-up in patients with inflammatory bowel diseases from the 2011 ECCO-EpiCom inception cohort
Z Vegh, J Burisch, N Pedersen, I Kaimakliotis, D Duricova, M Bortlik, Avnstrøm S, K Kofod Vinding, J Olsen, KR Nielsen, KH Katsanos, EV Tsianos, L Lakatos, D Schwartz, S Odes, G Lupinacci, A De Padova, L Jonaitis, L Kupcinskas, S Turcan, L F Barros, F Magro, D Lazar, A Goldis, A Fernandez, V Hernandez, O Niewiadomski, S Bell, P Munkholm and P L Lakatos for the EpiCom-group
J Crohns Colitis. 2015 Sep;9(9):747-53.
Polymorphisms in the Toll-like receptor and the IL-23/IL-17 pathways were associated with susceptibility to inflammatory bowel disease in a Danish cohort
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julied Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Marianne Kragh Thomsen, Vibeke Østergaard Thomsen, Morten Frydenberg, Bjørn Andersen Nexø, Jacob Sode, Ulla Vogel and Vibeke Andersen
PLoS One. 2015 Dec 23;10(12):e0145302
Faecal calprotectin measured by IBD patients at home - a new clinical tool
Kristoffer Kofod Vinding, Henriette Elsberg, Tine Thorkilgaard, Dorte Marker, Katrine Carlsen, Johan Burisch, P Munkholm
Inflamm Bowel Dis. 2016 Feb;22(2):336-44
The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease
Marcus Harbord, Vito Annese, Stephan Vavricka, Matthieu Allez, Manuel Barreiro De Acosta, Kirsten Borberg, Johan Burisch, Martine De Vos, Anne-Marie De Vries, Andrew Dick, Pascal Juillerat, Tom Karlsen, Ioannis Koutroubakis, Peter Lakatos, Tim Orchard, Pavol Papay, Tim Raine, Max Reinshagen, Diamant Thaci, Herbert Tilg, Franck Carbonne, for the European Crohn’s and Colitis Organization (ECCO)
J Crohns Colitis 2016;10(3):239–54
The Faroese IBD study - Incidence of Inflammatory Bowel Diseases in 54-years’ of population-based data
Turid Hammer, Kári R. Nielsen, Pia Munkholm, Johan Burisch, Elsebeth Lynge
J Crohns Colitis 2016;10(8):934–42
What Makes For A Good Mentor?
Iris Dotan, Johan Burisch
United European Gastroenterol J. 2016 Apr;4(2):320
Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
Louise Maagaard, Zsuzsanna Végh, Johan Burisch, Lisbeth Jensen, Natalia Pedersen, Pia Munkholm
World J Gastroenterol. 2016 Apr 21;22(15):4009-19.
Pre-clinical disease and preventive strategies in IBD: perspectives, challenges, and opportunities
Joana Torres, Johan Burisch, Mark Riddle, Marla Dubinsky, Jean-Frederic Colombel
Gut 2016;65(7):1061–9.
Using e-health strategies in delivering dietary and other therapies in IBS and IBD
Ankersen DV, Carlsen K, Marker D, Munkholm P, Burisch J
J Gastroenterol Hepatol 2017;32(Supplement S1):27–31.
Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy
Steffen Bank, Paal Skytt Andersen, Johan Burisch, Natalia Pedersen, Stine Roug, Julied Galsgaard, Stine Ydegaard Turino, Jacob Broder Brodersen, Shaista Rashid, Britt Kaiser Rasmussen, Sara Avlund, Thomas Bastholm Olesen, Hans Jürgen Hoffmann, Bjørn Andersen Nexø, Jacob Sode, Ulla Vogel and Vibeke Andersen
Pharmacogenomics J. 2018 Jan;18(1):87-97.
European Crohn's and Colitis Organisation Topical Review on environmental factors in IBD
Maaser C, Langholz E, Gordon H, Burisch J, Ellul P, Hernández Ramirez V, Karakan T, Katsanos KH, Krustins E, Levine A, Mantzaris GJ, O'Morain C, Saritas Yuksel E, Strid H, Annese V.
J Crohns Colitis 2017 2017;11:905–920.
[Editorial] What defines in treating patients with inflammatory bowel disease?
Theede K, Burisch J
Expert Rev Clin Immunol. 2017 Jul;13(7):645-647
Inflammatory Bowel Diseases in Faroese-born Danish residents and their offspring: is the risk of IBD driven by genetic or environmental factors?
Hammer T, Lophaven SN, Nielsen KR, 3, von Euler-Chelpin M, Weihe P, Munkholm P, Burisch J, Lynge E
Aliment Pharmacol Ther 2017;45(8):1107–14.
Letter: determining the dominant role of environmental factors in UC development-Authors' reply.
Hammer T, Lophaven SN, Burisch J, Lynge E
Aliment Pharmacol Ther. 2017 Jul;46(1):78-79.
The incidence of inflammatory bowel disease in Denmark 1980-2013: a nationwide cohort study
Lophaven SN, Lynge E, Burisch J
Aliment Pharmacol Ther 2017;45:961–972
Third European Evidence-Based Consensus on Diagnosis and Management Of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-Intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, And Ileo-Anal Pouch Disorders
Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B. Gecse, Ailsa L. Hart, Pieter Hindryckx, Cord Langner, Jimmy K. Limdi, Gianluca Pellino, Edyta Sylvwia Zagórowicz, Tim Raine, Marcus Harbord, Florian Rieder, for the European Crohn’s and Colitis Organisation (ECCO).
J Crohns Colitis. 2017 Jun 1;11(6):649-670.
Systematic review with meta-analysis: Proximal disease extension in limited ulcerative colitis
Giulia Roda, Neeraj Narula, Rachel Pinotti, Alexandros Skamnelos, Konstantinos H. Katsanos, Ryan Ungaro, Johan Burisch, Joana Torres, Jean-Frederic Colombel
Aliment Pharmacol Ther 2017;45:1481–1492
Low FODMAP diet reduces irritable bowel symptoms and improves quality of life in patients with inflammatory bowel disease in a randomized controlled trial
Natalia Pedersen, Dorit Vedel Andersen, Maria Felding, Zsuzsanna Végh, Johan Burisch, Jens Rikardt Andersen and, Pia Munkholm.
World J Gastroenterol 2017; 23(18): 3356-3366
Proximal disease extension in patients with limited ulcerative colitis: a Danish population-based inception cohort
Burisch J, Ungaro R, Vind I, Prosberg MV, Bendtsen F, Colombel J-F, Vester-Andersen MK
J Crohns Colitis. 2017 Oct 1;11(10):1200-1204
Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort – An ECCO-EpiCom study
Burisch J, Vegh Z, Katsanos KH, Christodoulou D, Lazar D, Goldis A, O’Morain C, Fernandez A, Pereira S, Myers S, Sebastian S, Pedersen N, Olsen J, Nielsen KR, Schwartz D, Odes S, Almer S, Halfvarson J, Turk N, Cukovic-Cavka S, Nikulina I, Belousova E, Duricova D, Bortlik M, Shonová O, Salupere R, Barros L, Magro F, Jonaitis L, Kupcinskas L, Turcan S, Kaimakliotis I, Ladefoged K, Kudsk K, Andersen V, Vind I, Thorsgaard N, Oksanen P, Collin P, Dal Piaz G, Santini A, Niewiadomski O, Bell S, Moum B, Arebi N, Kjeldsen J, Carlsen K, Langholz E, Lakatos PL, Munkholm P, Gerdes LU, Dahlerup JF
J Crohns Colitis. 2017 Oct 1;11(10):1213-1222
The Organisation and needs of the young sections belonging to UEG National Societies: results from a survey across Europe
Gianluca Ianiro, Valeria Castro, Werner Dolak, Madalina Ilie, Grainne Holleran, Maciej Salaga, Yasmijn van Herwaarden, Johan Burisch for the UEG Young Talent Group
United European Gastroenterol J. 2017 Aug;5(5):750-755
Whats “App-ening” – the help of new technologies in nutrition in digestive diseases
Dorit Vedel Ankersen, Petra Weimers, Johan Burisch
Curr Opin Clin Nutr Metab Care. 2017 Sep;20(5):426-431
European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal (‘Exit Strategies’) in Inflammatory Bowel Disease
Doherty, Glen; Katsanos, Konstantinos H; Burisch, Johan; Allez, Matthieu; Papamichael, Konstantinos; Stallmach, Andreas; Mao, Ren; Berset, Ingrid Prytz; Gisbert, Javier P; Sebastian, Shaji; Kierkuś, Jarosław; Lopetuso, Loris; Szymanska, Edyta; Louis, Edouard
J Crohns Colitis 2018;12:17–31.
[Editorial] The complexity of evaluating and increasing adherence in inflammatory bowel disease.
Weimers P, Burisch J, Munkholm P
Rev Esp Enferm Dig. 2017 Aug;109(8):539-541
How to start a Young GI Section in your country - A cookbook
Valeria Castro , Grainne Holleran , Gianluca Ianiro , Maciej Salaga , Madalina Ilie and Johan Burisch for the Young Talent Group, UEG.
United European Gastroenterol J. 2017 Oct; 5(6): 910–912.
Changes in disease behaviour and location in patients with Crohn’s disease after seven years of follow-up: a Danish population-based inception cohort
Lo B, Vester-Andersen MK, Vind I, Prosberg M, Dubinsky M, Siegel C, Bendtsen F, Burisch J
J Crohns Colitis 2018;12:265–272
Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index
Lo B, Prosberg M, Gluud LL, Chan W, Leong R, Van der list E, Var der have M, Sarter H, Gower-Rousseau C, Peyrin-Biroulet L, Vind I, Burisch J
Aliment Pharmacol Ther 2018;47:6–15.
Systematic review and meta-analysis of the Epidemiology of Inflammatory Bowel Disease in Racial and Ethnic Migrant groups
Ravi Misra, Omar Faiz, Pia Munkholm, Johan Burisch, Naila Arebi
World J Gastroenterol 2018;24:424–437.
[Editorial] The importance of detecting Irritable bowel-like symptoms in IBD patients
Weimers P, Burisch J
J Crohns Colitis. 2018 Mar 28;12(4):385-386.
Validation of the United Registries for Clinical Assessment and Research (UR-CARE), a European online registry for clinical care and research in Inflammatory Bowel Disease
Johan Burisch, Javier P. Gisbert, Britta Siegmund, Dominik Bettenworth, Sandra Bohn Thomsen, Isabelle Cleynen6, Anneline Cremer7, Nik John Sheng Ding8, Federica Furfaro9, Michail Galanopoulos, Philip Christian Grunert, Jurij Hanzel, Tamara Knezevic Ivanovski, Eduards Krustins, Nurulamin Noor, Neil O'Morain, Iago Rodríguez-Lago, Michael Scharl, Julia Tua, Mathieu Uzzan, Nuha Ali Yassin, Filip Baert, Ebbe Langholz
J Crohns Colitis. 2018 Apr 27;12(5):532-537
Vitamin D deficiency in a European Inflammatory Bowel disease inception cohort: An Epi-IBD study
Stefania Chetcuti Zammit, Pierre Ellul, Giulia Girardin, Danilea Valpiani, Kári Rubek Nielsen, Jóngerð Olsen, Adrian Goldis, Daniela Lazar, Olga Shonová, Shaji Sebastian, Emma Whitehead, Amalia Carmona, Jesus Martinez-Cadilla, Jens Frederik Dahlerup, Hendrika Adriana Linda Kievit, Niels Thorsgaard, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Fernando Magro, Riina Salupere, Natalia Pedersen, Jens Kjeldsen, Katrine Carlsen, Kaimaklioti Ioannis, Daniel Bergemalm, Jonas Halfvarson, Dana Duricova, Martin Bortlik, Pekka Collin, Pia Oksanen, Gediminas Kiudelis, Limas Kupcinskas, Karen Kudsk, Vibeke Andersen, Colm O'Morain, Yvonne Bailey, Doron Schwartz, Shmuel Odes, Sven Almer, Naila Arebi, Ravi Misra, Silvija Čuković-Čavka, Marko Brinar, Pia Munkholm, Zsuzsanna Vegh, Johan Burisch
Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1297-1303.
Efficacy of different fecal transplant protocols for the treatment of recurrent Clostridium difficile infection: a systematic review and metanalysis
Gianluca Ianiro, Marcello Maida, Johan Burisch, Claudia Simonelli, Antonio Gasbarrini, Giovanni Cammarota
United European Gastroenterol J. 2018 Oct;6(8):1232-1244.
Disease activity, steroid use and extraintestinal manifestations are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study.
Bobby Zhao Sheng Lo, Mette Bykærholm Julsgaard, Marianne Kajbæk Vester-Andersen, Ida Vind, Johan Burisch
Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1130-1136
The sex ratio of inflammatory bowel disease varies according to age at onset: results from a worldwide analysis
Shailja C. Shah*, Hamed Khalili*, Corinne Gower-Rousseau, Ola Olen, Eric Benchimol, Kári R. Nielsen, Elsebeth Lynge, Hyeong Sik Ahn, Da Yeong Yoon, Paul Brassard, Maria Vutcovici, Alain Bitton, Charles Bernstein, Desmond Leddin, Hala Tamim, Satimai Aniwan, Chung Yu Chen, Tryggvi Stefansson, Edward V. Loftus, Jr., Bjørn Moum, Whitney Tang, Siew Ng, Richard Gearry, Brankica Sincic, Sally Bell, Peter L. Lakatos, Zsuzsanna Végh, Claudia Ott, Gilaad Kaplan, Johan Burisch*, Jean-Frederic Colombel*
* contributed equally
Gastroenterology. 2018 Oct;155(4):1079-1089.
IBD2020 Global Forum: Results of an International Patient Survey on Quality of Care
Peter Irving, Johan Burisch, Richard Driscoll, Mats Olsson, John R. Fullarton, Barry S. Rodgers
Gray, Simon P.L. Travis
Intest Res. 2018 Oct;16(4):537-545.
Association between Inflammatory Bowel Disease and Parkinson’s Disease: a nationwide Swedish cohort study
Petra Weimers, Jonas Halfvarson, Michael C Sachs, Rachel Saunders-Pullman, Jonas F Ludvigsson,
Inga Peter*, Johan Burisch*, Ola Olén*
* contributed equally
Inflamm Bowel Dis. 2019 Jan 1;25(1):111-123
Inflammatory Bowel Disease and Parkinson's Disease: A Reply to Letter to the Editor of Shih-Wei Lai.
Weimers P, Halfvarson J, Saunders-Pullman R, Ludvigsson JF, Peter I, Olén O, Burisch J.
Inflamm Bowel Dis 2019, In press
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
Maaser, Christian; Sturm, Andreas; Vavricka, Stephan R; Kucharzik, Torsten; Fiorino, Gionata; Annese, Vito; Calabrese, Emma; Baumgart, Daniel C; Bettenworth, Dominik; Borralho Nunes, Paula; Burisch, Johan; Castiglione, Fabiana; Eliakim, Rami; Ellul, Pierre; González-Lama, Yago; Gordon, Hannah; Halligan, Steve; Katsanos, Konstantinos; Kopylov, Uri; Kotze, Paulo G; Krustinš, Eduards; Laghi, Andrea; Limdi, Jimmy K; Rieder, Florian; Rimola, Jordi; Taylor, Stuart A; Tolan, Damian; van Rheenen, Patrick; Verstockt, Bram; Stoker, Jaap; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]
J Crohns Colitis 2019;13:144–164.
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects
Sturm, Andreas; Maaser, Christian; Calabrese, Emma; Annese, Vito; Fiorino, Gionata; Kucharzik, Torsten; Vavricka, Stephan R; Verstockt, Bram; van Rheenen, Patrick; Tolan, Damian; Taylor, Stuart A; Rimola, Jordi; Rieder, Florian; Limdi, Jimmy K; Laghi, Andrea; Krustinš, Eduards; Kotze, Paulo G; Kopylov, Uri; Katsanos, Konstantinos; Halligan, Steve; Gordon, Hannah; González Lama, Yago; Ellul, Pierre; Eliakim, Rami; Castiglione, Fabiana; Burisch, Johan; Borralho Nunes, Paula; Bettenworth, Dominik; Baumgart, Daniel C; Stoker, Jaap; European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR]
J Crohns Colitis. 2019 Mar 26;13(3):273-284
Incidence and risk of inflammatory bowel disease in patients with psoriasis – a nationwide 20-year cohort study
Alexander Egeberg; Jacob P. Thyssen; Johan Burisch; Jean-Frederic Colombel
J Invest Dermatol. 2019 Feb;139(2):316-323
Natural disease course of ulcerative colitis during the first five years of follow-up in a European population-based inception cohort – an Epi-IBD study
Johan Burisch, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Luisa Barros, Fernando Magro, Natalia Pedersen, Jens Kjeldsen, Zsuzsanna Vegh, Peter L. Lakatos, Carl Eriksson, Jonas Halfvarson, Mathurin Fumery, Corinne Gower-Rousseau, Marko Brinar, Silvija Čuković-Čavka, Inna Nikulina, Elena Belousova, Sally Myers, Shaji Sebastian, Gediminas Kiudelis, Limas Kupcinskas, Doron Schwartz, Selwyn Odes, Ioannis P. Kaimakliotis, Daniela Valpiani, Renata D'Incà, Riina Salupere, Stefania Chetcuti Zammit, Pierre Ellul, Dana Duricova, Martin Bortlik, Adrian Goldis, Hendrika Adriana Linda Kievit, Alina Toca, Svetlana Turcan, Jóngerð Midjord, Kári Rubek Nielsen, Karina Winther Andersen, Vibeke Andersen, Ravi Misra, Naila Arebi, Pia Oksanen, Pekka Collin, Luisa de Castro, Vicent Hernandez, Ebbe Langholz, Pia Munkholm for the Epi-IBD group
J Crohns Colitis 2019;13:198–208.
Natural disease course of Crohn’s disease during the first five years after diagnosis in a European population-based inception cohort – an Epi-IBD study
Burisch J, Gediminas Kiudelis, Limas Kupcinskas, Hendrika Adriana Linda Kievit, Karina Winther Andersen, Vibeke Andersen, Riina Salupere, Natalia Pedersen, Jens Kjeldsen, Renata D'Incà, Daniela Valpiani, Doron Schwart, Selwyn Odes, Jóngerð Midjord, Kári Rubek Nielsen, Zsuzsanna Vegh, Peter L. Lakatos, Alina Toca, Svetlana Turcan, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Mathurin Fumery, Corinne Gower-Rousseau, Stefania Chetcuti Zammit, Pierre Ellul, Carl Eriksson, Jonas Halfvarson, Fernando Magro, Dana Duricova; Martin Bortlik, Alberto Fernandez, Vicent Hernandez, Sally Myers, Shaji Sebastian, Pia Oksanen, Pekka Collin, Adrian Goldis, Ravi Misra, Naila Arebi, Ioannis P. Kaimakliotis, Inna Nikulina, Elena Belousova, Marko Brinar, Silvija Čuković-Čavka, Ebbe Langholz, Munkholm P for the Epi-IBD group
Gut 2019, in press
A 10-year follow-up study of the natural history of perianal Crohn’s disease in a Danish population-based inception cohort
Mirabella Zhao, Bobby Zhao Sheng Lo, Marianne Vester-Andersen, Ida Vind, Flemming Bendtsen, Johan Burisch
Inflamm Bowel Dis. 2019 Jun 18;25(7):1227-1236
The Pathogenesis of Extraintestinal Manifestations: Implications for IBD research, diagnosis and therapy
Charlotte Hedin, Giorgios Bamias, Matthias Becker, Dominik Bettenworth, Johan Burisch, Pierre Ellul, Thomas Greuter, Anna Kagramanova, Kostas Katsanos, Yago Gonzalez Lama, Jochen Maul, Alexander Navarini, Uwe Pleyer, Tim Raine, Lluis Puig Sanz, Alain Schoepfer, Andy Stagg, Floris van Gaalen, Andrea van der Meulen, Stephan Vavricka, Florian Rieder
J Crohns Colitis. 2019 Apr 26;13(5):541-554
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study
Johan Burisch, Stefania Chetcuti Zammit, Pierre Ellul, Alina Toca, Svetlana Turcan, Dana Duricova; Martin Bortlik, Karina Winther Andersen, Vibeke Andersen, Ioannis P. Kaimakliotis, Mathurin Fumery, Corinne Gower-Rousseau, Giulia Girardin, Daniela Valpiani, Adrian Goldis, Marko Brinar, Silvija Čuković-Čavka, Pia Oksanen, Pekka Collin, Luisa Barros, Fernando Magro, Ravi Misra, Naila Arebi, Carl Eriksson, Jonas Halfvarson, Hendrika Adriana Linda Kievit, Natalia Pedersen, Jens Kjeldsen, Sally Myers, Shaji Sebastian, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Jóngerð Midjord, Kári Rubek Nielsen, Gediminas Kiudelis, Limas Kupcinskas, Inna Nikulina, Elena Belousova, Doron Schwartz, Selwyn Odes, Riina Salupere, Amalia Carmona, Juan R Pineda, Zsuzsanna Vegh, Peter L. Lakatos, Ebbe Langholz, Pia Munkholm for the Epi-IBD group
J Gastroenterol Hepatol. 2019 Jun;34(6):996-1003
Paradoxical Trends in Hospitalization Rates for the Inflammatory Bowel Diseases Between the Western World and Newly Industrialized Countries: A Study of the Organization for Economic Cooperation and Development (OECD)
James A King, Fox E Underwood, Nicola Panaccione, Josh Quan, Joseph W Windsor, Paulo Kotze, Siew C Ng, Subrata Ghosh, Peter L Lakatos, Tine Jess, Remo Panaccione, Cynthia Seow, Shomron Ben-Horin, Johan Burisch, Jean Fred Colombel, Ed Loftus, Richard Gearry, Jonas Halfvarson, Gilaad G Kaplan
Lancet Gastroenterol Hepatol. 2019 Apr;4(4):287-295
Health related quality of life in inflammatory bowel disease in a Danish unselected population- based inception cohort
Lea Katharina Christiansen, Bobby Lo, Flemming Bendtsen, Ida Vind, Marianne Vester-Andersen, Johan Burisch
United European Gastroenterol J. 2019 Aug;7(7):942-954
Colorectal cancer in Familial adenomatous polyposis patients: Results from the Danish Polyposis Registry
John Gásdal Karstensen, Johan Burisch, Hans-Christian Pommergaard, Lisa Aalling, Helle Højen, Niels Jespersen, Palle Nordblad Schmidt, Steffen Bülow
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2294-2300
Sex-based differences in incidence of inflammatory bowel diseases—pooled analysis of population-based studies from the East
Shailja C. Shah, Hamed Khalili, Chung-Yu Chen, Hyeong Sik Ahn, Siew C. Ng, Johan Burisch, Jean-Frederic Colombel
Aliment Pharmacol Ther. 2019 Apr;49(7):904-911
Polymorphisms in the NFkB, TNF-α, IL-1β, and IL-18 pathways were associated with response to anti-TNF therapy in two Danish cohorts of patients with inflammatory bowel diseases
Steffen Bank, Ann Christina Bergmann, Paal Skytt Andersen, Osama Karim Abed, Johan Burisch, Jacob Broder Brodersen, Natalia Konstantinovich Pedersen, Anja Gouliaev, Rullah Ajan, Ditlev Nytoft Rasmussen, Camilla Honore Grauslund, Stine Roug, Julied Galsgaard, Stine Ydegaard Turino, David Sprogøe Høyer Finsen, Karoline Lindby, Shaista Rashid, Britta Ørnfelt Lund, Britt Kaiser Rasmussen, Sara Avlund, Marie Ødum Nielsen, Eva Karolina Nilsdotter Bramstång, Anja Poulsen, Mette Julsgaard, Ditte Rudbeck-Resdal, Luise Aamann, Maria Joanna Alexandraki, Ali Foroutani, Line Molzen, Anders Hatrop, Charlotte Siggaard Rittig, Elisabeth Stenbøg, Nora Elisabeth Hedbäck, Rasmus Gaardskaer Nielsen, Frank Schiødt, Katrine Carlsen, Jeanette Sørensen, Lone Larsen, Malene Rohr Andersen, Ivan Brandslund, Ram Benny Dessau, Hans Jürgen
Hoffmann, Anders Green, Bjørn Andersen Nexø, Anders Bo Bojesen, Signe Bek Sørensen, Jacob Sode, Ulla Vogel, Vibeke Andersen
Aliment Pharmacol Ther. 2019;49(7):890-903.
[Editorial] Does eradication of Helicobacter pylori cause inflammatory bowel disease?
Johan Burisch, Tine Jess
Clin Gastroenterol Hepatol. 2019 Sep;17(10):1940-1941
Incidence of Immune-mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark
Johan Burisch, Tine Jess, Alexander Egeberg
Clin Gastroenterol Hepatol. 2019 Dec;17(13):2704-2712
The Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease
Mirabella Zhao, Johan Burisch
Dig Dis Sci. 2019 Jul;64(7):1759-1769
Direct and indirect costs of inflammatory bowel disease; ten years of follow up in a Danish population-based inception cohort
Lo B, Vind I, Vester-Andersen MK, Bendtsen F, Burisch J
J Crohns Colitis 2019, in press
Dietary risk factors for inflammatory bowel diseases in a high-risk population – results from the Faroese IBD study
Turid Hammer, Søren Nymand Lophaven, Kári Rubek Nielsen, Maria Skaalum Petersen, Pia Munkholm, Pál Weihe, Johan Burisch, Elsebeth Lynge
United European Gastroenterol J. 2019 Aug;7(7):924-932
Changing epidemiology of immune-mediated inflammatory diseases in immigrants: a systematic review of population-based studies
Manasi Agrawal, Shailja Shah, Anish Patel, Rachel Pinotti, Jean-Frederic Colombel, Johan Burisch
J Autoimmun. 2019 Dec;105:102303
Outcome of thiopurine-allopurinol combination therapy for inflammatory bowel disease: A nationwide Danish cohort study
Sandra Bohn Thomsen; Kristine Højgaard Allin; Johan Burisch; Camilla Bjørn Jensen; Susanne Hansen, Lise Lotte Gluud; Klaus Theede; Marianne Kiszka-Kanowitz; Anette Mertz Nielsen; Tine Jess
United European Gastroenterol J 2019, in press
Quality of care standards in inflammatory bowel diseases: a European Crohn’s and Colitis Organisation (ECCO) position paper
Gionata Fiorino, Theodore Lytras, Lisa Younge, Catarina Fidalgo, Sofie Coenen, Maria Chaparro, Mariangela Allocca, Ian Arnott, Peter Bossuyt, Johan Burisch, Marjo Campmans-Kuijpers, Lissy de Ridder, Axel Dignass, Ciara Drohan, Roger Feakins, Daniela Gilardi, Jan Grosek, Evelyn Groß, Ailsa Hart, Susanna Jäghult, Konstantinos Katsanos, Sanna Lonnfors, Yves Panis, Marko Perovic, Marieke Pierik, Jordi Rimola, Hagit Tulchinsky, Javier P. Gisbert on behalf of the European Crohn’s Colitis Organisation (ECCO)
J Crohns Colitis 2020, in press
Viewpoint: The changing epidemiology and economic impact of inflammatory bowel diseases among immigrants from low- to high-incidence countries
Manasi Agrawal, Johan Burisch, Jean-Frederic Colombel, Shailja Shah
J Crohns Colitis 2019, in press
Stopping 5-Aminosalicylate Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes.
Ungaro RC, Limketkai BN, Jensen CB, Yzet C, Allin KH, Agrawal M, Ullman T, Burisch J, Jess T, Colombel JF.
Clin Gastroenterol Hepatol. 2019, in press
Ethnic differences in inflammatory bowel disease: results from the UNited Kingdom IncepTion Epidemiology (UNITE) study
R Misra, J Limdi, R Cooney, M Brookes, E Fogden, S Pattni, N Sharma, S Sakuma, T Iqbal, P Munkholm, J Burisch, N Arebi
World J Gastroenterol. 2019 Oct 28;25(40):6145-6157
The epidemiology of inflammatory bowel disease: East meets West
Wing Yan Mak, Mirabella Zhao, Siew Chien Ng, Johan Burisch
Journal of Gastroenterology and Hepatology 2019, in press
Prevalence and associations between psoriasis and inflammatory bowel disease – A systematic review and meta-analysis
Farzad Alinaghi, Hasan Tekin, Johan Burisch, Jashin J. Wu, Jacob P. Thyssen, Alexander Egeberg
JCC 2019, in press
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres, Stefanos Bonovas, Glen Doherty, Torsten Kucharzik, Javier P. Gisbert, Tim Raine, Michel Adamina, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, […] on behalf of the European Crohn’s and Colitis Organisation (ECCO)
J Crohns Colitis 2019, in press
ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment
Michel Adamina, Stefanos Bonovas, Tim Raine, Antonino Spinelli, Janindra Warusavitarne, Alessandro Armuzzi, Oliver Bachmann, Palle Bager, Livia Biancone, Bernd Bokemeyer, Peter Bossuyt, Johan Burisch, […] on behalf of the European Crohn’s and Colitis Organisation (ECCO)
J Crohns Colitis 2019, in press
Current challenges and future needs of clinical and endoscopic training in Europe: An International Survey
Marcello Maida, Laith Al-Rubaiy, Guillaume Conroy, Louise China, Johan Burisch, Gianluca Ianiro
Endoscopy International Open, 2019 in press
[Editorial] "The sooner the better? Cost-effectiveness of early biological therapy in patients with Crohn’s disease
Mirabella Zhao, Johan Burisch
J Crohns Colitis 2019, in press
The Prevention and Management of Crohn’s Disease Post-operative Recurrence: Results from the Y-ECCO/ClinCom 2019 Survey
Gabriele Dragoni, Nik Ding, Gecse KB, Mansfield JC, Kopylov U, Beaugerie L, Bossuyt P, Sebastian S, Milla M, Bagnoli S, Yassin NA, Bettenworth D, Burisch J, Hedin C, Gisbert JP and Marc Ferrante; on behalf of Clinical Research Committee of ECCO (ClinCom) and Young ECCO Committee (Y-ECCO).
EJGH 2020, in press
High occurrence and infrequent evaluation of osteoporosis in patients with inflammatory bowel disease - a Danish population-based inception cohort with 10 years of follow-up
Lo B, Holm JP, Vester-Andersen MK, Bendtsen F, Vind I, Burisch J
J Crohns Colitis 2020, in press
Healthcare costs of inflammatory bowel disease in a pan-European, community-based inception cohort during five years of follow-up – a population-based study
Johan Burisch, Hillel Vardi, Doron Schwartz, Michael Friger, Gediminas Kiudelis, Juozas Kupčinskas, Mathurin Fumery, Corinne Gower-Rousseau, Laszlo Lakatos, Peter L. Lakatos, Renata D'Incà, Alessandro Sartini, Daniela Valpiani, Martina Giannotta, Naila Arebi, Dana Duricova, Martin Bortlik, Stefania Chetcuti Zammit, Pierre Ellul, Natalia Pedersen, Jens Kjeldsen, Jóngerð Maria Miné Midjord, Kári Rubek Nielsen, Karina Winther Andersen, Vibeke Andersen, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Viktor Domislovic, Zeljko Krznaric, Shaji Sebastian, Pia Oksanen, Pekka Collin, Luisa Barros, Fernando Magro, Riina Salupere, Hendrika Adriana Linda Kievit, Adrian Goldis, Ioannis P. Kaimakliotis, Jens F. Dahlerup, Carl Eriksson, Jonas Halfvarson, Alberto Fernandez, Vicent Hernandez, Svetlana Turcan, Elena Belousova, Ebbe Langholz, Pia Munkholm, Selwyn Odes, for the Epi-IBD group
The Lancet Gastroenterology & Hepatology 2020, in press
Telemedicin til monitorering af inflammatoriske tarmsygdomme og colon irritabile [Danish]
Malte Rosager Hansen, Dorit Vedel Ankersen, Dorte Marker, Katrine Carlsen, Mette Bennedsen, Eva Fjordside, Charlotte Teglgaard Peters-Lehm, Vibeke Wewer, Pia Munkholm, Johan Burisch
Ugeskrift for Læger 2020, in press
Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease: A Population-Based Danish Cohort Study
Victoria S Kjærgaard, Camilla B Jensen, Johan Burisch, Kristine Allin, Tine Jess
Gastroenterology. 2020 Oct;159(4):1609-1611.
Risk for development of inflammatory bowel disease under inhibition of interleukin 17: a review and meta-analysis
Johan Burisch, Wolfgang Eigner, Stefan Schreiber, Daniel Aletaha, Wolfgang Weninger, Michael Trauner, Walter Reinisch, Neeraj Narula
PLoS One. 2020 May 27;15(5):e0233781
Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study.
Zhao M, Bendtsen F, Petersen AM, Larsen L, Dige A, Hvas C, Seidelin JB, Burisch J.
BMJ Open. 2020 Feb 25;10(2):e035756
Incidence and prevalence of microscopic colitis between 2001 and 2016: A nationwide Danish cohort study
Petra Weimers, Dorit Vedel Ankersen, Søren Lophaven, Ole Bonderup, Andreas Münch, Ellen
Christine Leth Løkkegaard, Johan Burisch, Pia Munkholm
J Crohns Colitis 2020, in press
Authors' response: Interpretations of trends in incidence of microscopic colitis
Petra Weimers, Dorit Vedel Ankersen, Ole K Bonderup, Ellen Christine Leth Løkkegaard, Johan Burisch, Pia Munkholm
J Crohns Colitis. 2021 Feb 1;15(2):344
The Incidence and Disease Course of Perianal Crohn’s Disease: A Danish Nationwide Cohort Study, 1997-2015
Wewer MD, Zhao M, Nordholm-Carstensen A, Seidelin JB, Burisch J
J Crohns Colitis 2021;15:5–13.
Systematic review of the prevalence and development of osteoporosis and its risk factors in patients with inflammatory bowel disease
Sofia Kärnsund, Bobby Lo, Flemming Bendtsen, Johan Burisch
World J Gastroenterol. 2020 Sep 21;26(35):5362-5374
Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases.
Mohamed Attauabi, Mirabella Zhao, Flemming Bendtsen, Johan Burisch
Inflamm Bowel Dis. 2021 May 17;27(6):927-939
The use of 5-aminosalicylates for patients with Crohn’s disease in a prospective European inception cohort with five years follow-up – the Epi-IBD cohort
Johan Burisch, Carl Eriksson, Jonas Halfvarson, Viktor Domislovic, Zeljko Krznaric, Adrian Goldis, Jens F. Dahlerup, Pia Oksanen, Pekka Collin, Alberto Fernandez, Vicent Hernandez, Svetlana Turcan, Elena Belousova, Renata D'Incà, Alessandro Sartini, Daniela Valpiani, Martina Giannotta, Ravi Misra, Naila Arebi, Dana Duricova, Martin Bortlik, Kelly Gatt, Pierre Ellul, Natalia Pedersen, Jens Kjeldsen, Karina Winther Andersen, Vibeke Andersen, Konstantinos H. Katsanos, Dimitrios K. Christodoulou, Shaji Sebastian, Luisa Barros, Fernando Magro, Jóngerð Maria Miné Midjord, Kári Rubek Nielsen, Riina Salupere, Hendrika Adriana Linda Kievit, Gediminas Kiudelis, Juozas Kupčinskas, Mathurin Fumery, Corinne Gower-Rousseau, Ioannis P. Kaimakliotis, Doron Schwartz, Selwyn Odes, Laszlo Lakatos, Peter L. Lakatos, Ebbe Langholz, Pia Munkholm for the Epi-IBD group
United European Gastroenterol J. 2020 Oct;8(8):949-960
Validation of ulcerative colitis and Crohn’s disease and their phenotypes in the Danish National Patient Registry using a population-based cohort
Bobby Lo, Ida Vind, Marianne Kajbæk Vester-Andersen, Johan Burisch
Scand J Gastroenterol. 2020 Oct;55(10):1171-1175
The risk of extra-intestinal cancer in inflammatory bowel disease: an updated systematic review and meta-analysis of population-based cohort studies
Bobby Lo, Mirabella Zhao, Ida Vind, Johan Burisch
Clin Gastroenterol Hepatol. 2021 Jun;19(6):1117-1138
eHealth: Disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis
Dorit Vedel Ankersen, Petra Weimers, Dorte Marker, Thor Johannesen, Søren Iversen, Berit Lilje, Anja Bråthen Kristoffersen, Sanaz Saboori, Kristine Paridaens, Paal Skytt Andersen, Johan Burisch, Pia Munkholm,
Scand J Gastroenterol. 2020 Nov;55(11):1291-1300
Disease Activity Patterns, Mortality, and Colorectal Cancer Risk in Microscopic Colitis: A Danish Nationwide Cohort Study, 2001 to 2016.
Petra Weimers, Dorit Vedel Ankersen, Søren N. Lophaven, Ole K. Bonderup, Andreas Münch, Ellen Christine Leth Løkkegaard, Pia Munkholm, Johan Burisch
J Crohns Colitis. 2021 Apr 6;15(4):594-602
Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease – A Danish prospective population-based cohort study
Mohamed Attauabi, Anja Poulsen, Klaus Theede, Natalia Petersen, Lone Larsen, Tine Jess, Luca Malte Rosager Hansen, Marianne Kajbæk Vester-Andersen, Kent Haderslev, Anders Berg Lødrup, Akbar Molazahi, Anders Neumann, Abdel Wase, Jakob Benedict Seidelin, Johan Burisch, on behalf of the Danish COVID-IBD Study Group
J Crohns Colitis. 2021 Apr 6;15(4):540-550
Authors’ Reply to: “COVID-19 in the IBD Population: The Need for Correct Nomenclature
Mohamed Attauabi, Jakob Benedict Seidelin, Johan Burisch
J Crohns Colitis. 2021 Jun 22;15(6):1080
Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study.
Mohamed Attauabi, Johan Burisch, Jakob Benedict Seidelin
Inflamm Bowel Dis. 2021 Feb 16;27(3):e37-e38
Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature
Mohamed Attauabi, Johan Burisch, Jakob Benedict Seidelin
Scand J Gastroenterol. 2021 Jan;56(1):53-58
Occurrence of colorectal cancer and the influence of medical treatment in inflammatory bowel disease patients: A Danish nationwide cohort study between 1997 and 2015
Petra Weimers, Dorit Vedel Ankersen, Ellen Løkkegaard, Johan Burisch, Pia Munkholm
Inflam Bowel Dis. 2020, in press
A Danish population-based case series of patients with liver cirrhosis and coronavirus disease 2019
Mohamed Attauabi, Johan Burisch, Flemming Bendtsen, Nina Kimer
Scand J Gastroenterol. 2021 Apr;56(4):453-457
Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
Mohamed Attauabi, Jakob Benedict Seidelin, Oluf Krautwald Felding, Mads Damsgaard Wewer, Laura Kirstine Vinther Arp, Melek Zahra Sarikaya, Alexander Egeberg, Nora Vladimirova, Flemming Bendtsen, Johan Burisch
Journal of Autoimmunity 2021, in press
Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease
Johan Burisch, He Zhang, Casey Kar-Chan Choong, David Nelson, April Naegeli, Theresa Gibble, Iris Goetz, Alexander Egeberg
Therapeutic Advances in Gastroenterology 2021, in press
Costs of electronic health vs. standard care management of inflammatory bowel disease with three years follow up - a Danish register-based study
Dorit Vedel Ankersen, Petra Weimers, Dorte Marker, Charlotte Teglgaard Peters-Lehm, Mette Bennedsen, Malte Rosager Hansen, Jens Olsen, Maria Elmegaard Madsen, Johan Burisch, Pia Munkholm
Scand J Gastroenterol. 2021 May;56(5):520-529
The burden of inflammatory bowel disease in Europe 2020
Mirabella Zhao, Lorant Gönczi, Peter L Lakatose, Johan Burisch
J Crohns Colitis. 2021 Sep 25;15(9):1573-1587
Patient reported outcomes in chronic inflammatory diseases: Where are we now?
Florian Tran, Ilka Ratjen, Wolfgang Lieb, Philip Helliwell, Johan Burisch, Juliane Schulz, Florian Schrinner, Charlot Jaeckel, Ulf Müller-Ladner, Stefan Schreiber, Bimba F. Hoyer
Frontiers in Immunology 2021, in press
Systematic review and meta-analysis: The impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease
Mohamed Attauabi, Mirabella Zhao, Flemming Bendstsen, Johan Burisch
Therapeutic Advances in Gastroenterology 2021, in press
Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn’s disease – a real-world two-center cohort study
Mohamed Attauabi, Ida Vind, Gitte Pedersen, Flemming Bendtsen, Jakob Benedict Seidelin, Johan Burisch
EJGH 2021, in press
COVID-19-related personal product shortages are associated with psychological distress in people living with gastrointestinal disorders: A cross-sectional survey
Antonina Mikocka-Walus; David Skvarc; Miranda A.L. van Tilburg; Manuel Barreiro-de Acosta; Floor Bennebroek Evertsz; Charles N Bernstein; Johan Burisch; Nuno Ferreira; Richard B. Gearry; Lesley A Graff; Sharon Jedel; Anna Mokrowiecka; Andreas Stengel; Simon Knowles
Neurogastroenterology and Motility 2021, in press
Validation and update of the Lémann index to measure cumulative structural bowel damage in Crohn’s disease.
Pariente B, Torres J, Burisch J, Arebi N, Lambert J, Basrberio B, Duricova D, Ellul P, Goldis A, Kaimakliotis J, Katsanos K, Krznaric Z, Mc Namara D, Pedersen N, Sebastian S, Azahaf M, Weimars P, Lung P, Lacognata C, Horak M, Domislovic V, Murphy I, Ungaro R, Colombel JF, Mary JY
Gastroenterology. 2021 Sep;161(3):853-864
Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis.
de Frias Gomes CG, de Almeida ASR, Mendes CCL, Ellul P, Burisch J, Buhagiar T, Attard A, Lo B, Ungaro RC, da Silva Morão BT, Gouveia CF, de Carvalho E Branco JMD, Rodrigues JMMP, Teixeira C, Dias de Castro MFF, Nunes GFD, Brito M, de Sousa Antunes MC, Borralho Nunes PMFB, da Silva Torres JMT.
Inflamm Bowel Dis. 2021, in press
Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: A real-world, nationwide cohort of patients with inflammatory bowel diseases
Mohamed Attauabi, Camilla Höglund, Janne Fassov, Camilla Höglund, Kenneth Bo Pedersen, Heidi Bansholm Hansen, Signe Wildt, Michael Dam Jensen, Anders Neumann, Cecilie Lind, Henrik Albæk Jacobsen, Ana-Maria Popa, Jens Kjeldsen, Natalia Pedersen, Akbar Molazahi, Kent Haderslev, Torben Knudsen, Lone Larsen, Wojciech Cebula, Pia Munkholm, Flemming Bendtsen, Jakob Benedict Seidelin, Johan Burisch
Scand J Gastroenterol. 2021 Sep;56(9):1040-1048
ECCO Topical Review: Refractory Inflammatory Bowel Disease.
Timothy Raine, Bram Verstockt, Uri Kopylov, Konstantinos Katsanos, Rima Goldberg, Raja Atreya, Johan Burisch, John Burke, Pierre Ellul, Charlotte Hedin, Stefan Holubar, Konstantinos Karmiris, Triana Lobaton Ortega, Carsten Schmidt, Garret Cullen
J Crohns Colitis. 2021 Oct 7;15(10):1605-1620
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: a Multi-Center Retrospective Cohort Study
Ahmad Albshesh , Joshua Taylor, Edoardo V. Savarino, Marie Truyens, Alessandro Armuzzi, Davide Giuseppe Ribaldone, Ariella Bar-Gil Shitrit, Morine Fibelman, Pauliina Molander, Claire Liefferinckx, Stéphane Nancey, Mohamed Korani, Mariann Rutka, Manuel Barreiro-de Acosta, Viktor Domislovic, Gerard Suris, Carl Eriksson, Catarina Alves, Afroditi Mpitouli, Caroline di Jiang, Katja Tepeš, Marina Coletta, Kalliopi Foteinogiannopoulou, Javier P Gisbert, Hadar Amir-Barak, Mohamed Attauabi, Jakob B. Seidelin, Waqqas Afif, Carla Marinelli, Triana Lobaton, Daniela Pugliese, Nitsan Maharshak, Anneline Cremer, Jimmy Limdi, Tamás Molnár, Borja Otero-Alvarin, Zeljko KrznarIc, Fernando Magro, Konstantinos Karmiris, Tim Raine, David Drobne, Ioannis Koutroubakis, María Chaparro, Henit Yanai, Johan Burisch, Uri Kopylov
Journal of Clinical Medicine 2021, in press
The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: a protocol of an international collaborative study
Nuno Ferreira, Antonina Mikocka-Walus, Miranda A.L. van Tilburg, Lesley A. Graff, Pragalathan Apputhurai, Manuel Barreiro de Acosta, Floor Bennebroek Evertsz, Johan Burisch, Bobby Lo, Megan Petrik, Inês A. Trindade, Sharon Jedel, Gabriele Moser, Anna Mokrowiecka, Charles N. Bernstein, Dan Dumitrascu, Alexander C. Ford, Andreas Stengel, Richard Gearry, Simon R. Knowles
Journal of Psychosomatic Research, 2021, in press
Microscopic colitis in Denmark: regional variations in risk factors and endoscopic activity
Petra Weimers, Dorit Vedel Ankersen, Søren N. Lophaven, Ole K. Bonderup, Andreas Münch, Elsebeth Lynge, Ellen Christine Leth Løkkegaard, Pia Munkholm, Johan Burisch
J Crohns Colitis 2021, in press
Point-of-care testing and home testing: pragmatic considerations for widespread incorporation: stool tests, serum tests, intestinal ultrasound
Rune Wilkens, Michael Dolinger, Johan Burisch, and Christian Maaser
Gastroenterology 2022, in press
ECCO Topical Review on Clinicopathological Spectrum & Differential Diagnosis of IBD.
Roger Feakins, Joana Torres, Paula Borralho-Nunes, Johan Burisch, Tiago Cúrdia Gonçalves, Lissy De Ridder, Ann Driessen, Triana Lobatón, Luis Menchén, Aart Mookhoek, Nurulamin Noor, Magali Svrcek, Vincenzo Villanacci, Nina Zidar, Monika Tripathi
J Crohns Colitis 2021, in press
The role of artificial intelligence assisted assessment of endoscopy among inflammatory bowel disease
Bobby Lo, Johan Burisch
Artif Intell Gastrointest Endosc 2021, in press
Exploring the relationship between self-isolation and distress among people with gastrointestinal disorders during the COVID-19 pandemic
Antonina Mikocka-Walus; David Skvarc; Manuel Barreiro-de Acosta; Floor Bennebroek; Charles N. Bernstein; Johan Burisch; Nuno Ferreira; Richard B. Gearry; Lesley A. Graff; Sharon Jedel; Anna Mokrowiecka; Andreas Stengel; Ines A Trindade; Miranda A.L. van Tilburg; Simon R Knowles
Journal of Clinical Psychology in Medical Setting 2021, in press
Outcomes and long-term effects of COVID-19 in patients with inflammatory bowel diseases - a Danish prospective population-based cohort study with individual-level data
Mohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, Malte Rosager Hansen, Marianne Kajbæk Verner-Andersen, Sule Eraslan, August Pilegaard Prahm, Natalia Pedersen, Lone Larsen, Tine Jess, Anders Neumann, Kent V Haderslev, Akbar Molazahi, Anders Berg Lødrup, Henning Glerup, Asser Mathiassen Oppfeldt, Michael Dam Jensen, Klaus Theede, Marianne Kiszka-Kanowitz, Jakob Benedict Seidelin, Johan Burisch, on behalf of the Danish COVID-IBD Study Group
J Crohns Colitis 2021, in press
Extending the Common Sense Model to Explore the Impact of the Fear of COVID-19 on Quality of Life in an International Inflammatory Bowel Disease Cohort
Bree Hayes, Pragalathan Apputhurai, Antonina Mikocka-Walus, Manuel Barreiro-de Acosta, Charles N. Bernstein, Rebecca Burgell, Johan Burisch, Floor Bennebroek Evertsz, Nuno Ferreira, Lesley A. Graff, Inês A. Trindade, Richard Gearry, Bobby Lo, Anna Mokrowiecka, Gabriele Moser, Megan Petrik, Andreas Stengel & Simon R. Knowles
Journal of Clinical Psychology in Medical Settings 2021, in press
The clinical course of Crohn’s disease in a Danish population-based inception cohort with more than fifty years of follow-up 1962-2017
Johan Burisch, Søren Lophaven, Ebbe Langholz, Pia Munkholm
Aliment Pharmal 2021, in press
Editorial: delving into the natural history of Crohn’s disease and the impact of medical therapy - authors' reply
Johan Burisch, Ebbe Langholz, Pia Munkholm
Aliment Pharmal 2021, in press
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?
Attauabi M, Seidelin J, Burisch J; Danish COVID-IBD Study Group.
Gut. 2021 Oct;70(10):2020-2022
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
Tim Raine, Stefanos Bonovas, Johan Burisch, Torsten Kucharzik, Michel Adamina, Vito Annese, Oliver Bachmann, Dominik Bettenworth, Maria Chaparro-Sanchez, Wladyslawa Czuber-Dochan, Piotr Eder, Pierre Ellul, Catarina Fidalgo, Gionata Fiorino, Paolo Gionchetti, Javier P Gisbert, Hannah Gordon, Charlotte Hedin, Stefan Holubar, Marietta Iacucci, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Peter Lakatos, Theodore Lytras, Ivan Lyutakov, Nurulamin Noor, Gianluca Pellino, Daniele Piovani, Edoardo Savarino, Francesco Selvaggi, Bram Verstockt, Antonino Spinelli, Yves Panis, Glen Doherty
J Crohns Colitis 2021, in press
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
Antonino Spinelli, Stefanos Bonovas, Johan Burisch, Torsten Kucharzik, Michel Adamina, Vito Annese, Oliver Bachmann, Dominik Bettenworth, Maria Chaparro-Sanchez, Wladyslawa Czuber-Dochan, Piotr Eder, Pierre Ellul, Catarina Fidalgo, Gionata Fiorino, Paolo Gionchetti, Javier P Gisbert, Hannah Gordon, Charlotte Hedin, Stefan Holubar, Marietta Iacucci, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Peter Lakatos, Theodore Lytras, Ivan Lyutakov, Nurulamin Noor, Gianluca Pellino, Daniele Piovani, Edoardo Savarino, Francesco Selvaggi, Bram Verstockt, Glen Doherty, Tim Raine, Yves Panis
J Crohns Colitis 2021, in press
Long-term effects of a web-based low FODMAP diet vs. probiotic treatment for irritable bowel syndrome, including shotgun analyses of microbiota: a randomized, double crossover clinical trial.
Dorit Vedel Ankersen, Petra Weimers, Mette Bennedsen, Anne Haaber, Eva Fjordside, Moritz E. Beber, Christian Lieven, Sanaz Saboori, Nicolai Ditzel Vad, Terje Rannem, Dorte Marker, Kristine Paridaens, Suzanne Fram, Lisbeth Jensen, Malte Rosager Hansen, Johan Burisch, Pia Munkholm
Journal of Medical Internet Research 2021, in press
Validation of the endoscopic assessment of Spigelman classification for evaluation of duodenal adenomatosis in familial adenomatous polyposis – a prospective study of the interobserver reliability
Karstensen JG, Bülow S, Burisch J, Ellebæk MB, Ostapiuk MA, Pommergaard HC, Schmidt PN
American J Gastroenterol 2021, submitted
Surgery, cancer and mortality among patients with ulcerative colitis in a Danish population-based cohort with more than fifty years of follow-up 1962-2017
Johan Burisch, Søren Lophaven, Pia Munkholm, Ebbe Langholz
Aliment Pharmacol Ther 2021, in press
JOHAN BURISCH MD,PhD
Copyright @ All Rights Reserved